Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
06/2002
06/13/2002CA2430524A1 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002CA2430191A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002CA2425396A1 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
06/12/2002EP1213348A2 Parasite-derived resistance
06/12/2002EP1212941A2 Modulating ramp activity
06/12/2002EP1212436A2 Protein phosphatase and kinase proteins
06/12/2002EP1212429A2 Luciferase expression cassettes and methods of use
06/12/2002EP1212422A2 Human ctla-4 antibodies and their uses
06/12/2002EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies
06/12/2002EP1212076A2 Stimulation of sperm function
06/12/2002EP1211933A1 Pa28 modified transgenic mice
06/12/2002EP1211932A2 A method of transgenic fowl construction
06/12/2002EP1211931A1 A knockout mouse for the tumor suppressor gene anx7
06/12/2002EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
06/12/2002CN2494597Y Small silkworms cobreeding apparatus
06/12/2002CN1352996A Method of recording polarized electromagnetic radiation of microorganism deactivated strain, its equipment and application
06/12/2002CN1086104C Labour-saving silkworm-rearing table
06/11/2002US6403557 Fibroblast growth factor-13
06/11/2002US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics
06/11/2002CA2082390C Dna encoding human 5-ht1d receptors and uses thereof
06/06/2002WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases
06/06/2002WO2002044422A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
06/06/2002WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002WO2002044364A2 Polypeptides involved in immune response
06/06/2002WO2002044321A2 Rna interference mediating small rna molecules
06/06/2002WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies
06/06/2002WO2002043477A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
06/06/2002WO2002014473A3 Animals expressing exogenous igf-i in their milk
06/06/2002WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/06/2002WO2001090334A3 Drug metabolizing enzymes
06/06/2002WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
06/06/2002US20020069423 Prion-free transgenic ungulates
06/06/2002US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects
06/06/2002US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody.
06/06/2002US20020068715 DNA construct comprising a sequence encoding an autoantigen associated with a pro-inflammatory, Th1-type T cell response, under the regulatory control of a promoter that is active in a mammalian host.
06/06/2002US20020068713 Genetic engineering of vascular grafts to resist disease
06/06/2002US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells
06/06/2002US20020068358 In vitro embryo culture device
06/06/2002US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents
06/06/2002US20020068329 Fusion proteins for prodrug activation
06/06/2002CA2822983A1 System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
06/06/2002CA2791831A1 Rna interference mediating small rna molecules
06/06/2002CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002CA2430473A1 Diagnosis and treatment of disease
06/06/2002CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002CA2430054A1 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
06/06/2002CA2429814A1 Rna interference mediating small rna molecules
06/06/2002CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders
06/06/2002CA2402459A1 Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
06/05/2002EP1211313A2 Modulation of PDE11A activity
06/05/2002EP1210875A1 Modulating gene expression in insects by using double-stranded RNA (dsRNA)
06/05/2002EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
06/05/2002EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
06/05/2002EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6
06/05/2002EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression
06/05/2002EP1210441A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof
06/05/2002EP1210408A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
06/05/2002EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same
06/05/2002EP1210374A1 Human monoclonal antibodies to prostate specific membrane antigen
06/05/2002EP1210372A2 Human monoclonal antibodies to her2/neu
06/05/2002EP1210123A1 Single-stranded oligodeoxynucleotide mutational vectors
06/05/2002EP1209968A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity
06/05/2002EP0612211B1 Alteration of rate and character of hair growth
06/05/2002CN1352523A MSH 5 ablated mice and usest therefor
06/05/2002CN1351826A Fast cultivation technology for rare mossback
06/04/2002US6399758 Nucleic acid encoding a glycosyltransferase of porcine origin useful in decreasing unwanted carbohydrate epitopes in cells by having a higher affinity for the substrate than a second glycosyl transferase; use in xenotransplantation
06/04/2002US6399373 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/04/2002US6399350 Screening for modulators by exposing kuz polypeptide to protease substrate in presence of modulating agent which can be an antibody, dominant negative fragment of the polypeptide or enzyme inhibitor
06/04/2002US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents
06/04/2002US6399300 Recombinant embryonic cardiomyocyte cell having two constructs which are selectable marker genes under control of separate promoters; gene therapy; drug screening
06/04/2002US6399118 Enriching with essential fatty acids, vaccines, hormones, immunostimulants, attractants, nutrients and pigments using liposomes; dehydration; rehydrating and feeding to aquaculture organisms
06/04/2002US6398800 Method for testing a technique intended to predict onset of heart arrhythmia using an animal test subject
06/04/2002US6397782 Butterfly rearing kit
06/04/2002CA2331934A1 Protein and its encoding nucleotide sequences for diagnosis, prevention and treatment of lung injuries and disorders
05/2002
05/30/2002WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/30/2002WO2002042455A2 Modifier of organelle metalbolism
05/30/2002WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/30/2002WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
05/30/2002WO2002012437A3 Production of humanized antibodies in transgenic animals
05/30/2002WO2001094598A3 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells
05/30/2002WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/30/2002WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
05/30/2002WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof
05/30/2002WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals
05/30/2002WO2001053473A3 Methods for amplifying genetic material and uses thereof
05/30/2002WO2001040264A9 Peptide antigens
05/30/2002WO2001039799A9 Passive desensitization
05/30/2002WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells
05/30/2002US20020066117 Transgenic animal and methods
05/30/2002US20020066116 Endometriosis mouse model
05/30/2002US20020065538 Method and device for recording polarized electromagnetic radiation of inactivated strain of pathogenic microorganisms onto a crystal, method and device for changing activity of strain of pathogenic microorganisms, method for eliminating strain of pathogenic microorganisms from human or animal organism
05/30/2002US20020065213 Increasing the duration of expression of a delivered gene in target cells by delivering a gene encoding a cellular retention activity and nuclear binding sequence to target cells before or during gene of interest delivery
05/30/2002US20020065210 DcR3 polypeptide, a TNFR homolog
05/30/2002US20020064876 Genetically engineering cells of skin; obtain cells, transform with expression vector, monitor cells for preferential phenotypes
05/30/2002US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/30/2002US20020064527 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening